8
H. Tamiaki et al. / Bioorganic & Medicinal Chemistry xxx (2017) xxx–xxx
26.28, 25.89, 20.05, 17.74, 16.13, 16.03; HRMS (APCI) found: m/z
291.2682, calcd for C20H35O: [MꢂH]+, 291.2682; see also the spec-
tral data of its racemic mixture in Ref. 18.
3-CH3), 1.61, 1.60 (each 3H, s, 7-CH3, 15-CH3 cis to C14ACH2),
1.47–1.25, 1.17–1.04 (5H+2H, m, 8-CH2CH2CHCH2), 0.87 (3H, d,
J = 7 Hz, 11-CH3); 13C NMR (CD3OD, 151 MHz) d = 139.44, 136.42,
131.84, 126.04, 125.10, 124.93, 59.44, 40.97, 40.75, 38.29, 37.52,
33.40, 27.40, 26.56, 26.37, 25.90, 20.08, 17.73, 16.26, 15.94; HRMS
(APCI) found: m/z 291.2678, calcd for C20H35O: [MꢂH]+, 291.2682;
see also the spectral data of the (11R)-epimer in Ref. 27.
4.2.2. 10,11-Dihydrogeranylgeraniol (6b)
To a solution of geraniol (1b, 4.45 g, 28.8 mmol) in dichloro-
methane (15 ml) were added DMAP (175 mg, 1.43 mmol) and acetic
anhydride (6.0 ml, 63 mmol) and the mixture was stirred at room
temperature under nitrogen for 1 h. After addition of methanol
(10 ml), the reaction mixture was further stirred for 1 h, diluted with
diethyl ether, washed twice with aq. 4% sodium hydrogen carbon-
ate, distilled water, and brine, and dried over sodium sulfate. The
solvents were evaporated and the residue was purified with FCC
(hexane:ethyl acetate = 20:1) to give geranyl acetate (2b, 4.04 g,
20.6 mmol) in 71% yield: colorless oil; 1H NMR (CDCl3, 400 MHz)
d = 5.34 (1H, t, J = 7 Hz, 2-H), 5.08 (1H, t, J = 7 Hz, 6-H), 4.58 (2H, d,
J = 7 Hz, CH2O), 2.13–2.03 (4H, m, 3-CH2CH2), 2.06 (3H, s, 1-
OCOCH3), 1.70 (3H, s, 3-CH3), 1.68 (3H, s, 7-CH3 trans to C6ACH2),
1.60 (3H, s, 7-CH3 cis to C6ACH2); see also its spectral data in Ref. 15.
The above acetate 2b (1.02 g, 5.20 mmol) was dissolved in
dichloromethane (10 ml) and cooled down to 0 °C, to which were
added an aqueous 70% tert-butyl hydroperoxide solution (1.8 ml,
13 mmol), salicylic acid (88 mg, 0.64 mmol), and selenium oxide
(30 mg, 0.27 mmol). The mixture was stirred at room temperature
for 2 days and the reaction was quenched with distilled water. After
extraction with diethyl ether, the organic phase was washed twice
with distilled water and brine and dried over sodium sulfate. All the
solvents were evaporated and the residue was purified with FCC
(hexane:ethyl acetate = 4:1) to give 8-hydroxy-farnesyl acetate
(3b, 505 mg, 2.38 mmol) in 46% isolated yield: colorless oil; 1H
NMR (CDCl3, 600 MHz) d = 5.38–5.33 (2H, m, 2-, 6-H), 4.58 (2H, d,
J = 7 Hz, CH2OAc), 3.99 (3H, s, 7-CH2), 2.19–2.08 (4H, m, 3-CH2CH2),
2.05 (3H, s, 1-OCOCH3), 1.71 (3H, s, 7-CH3), 1.66 (3H, s, 3-CH3) [The
8-OH was invisible.]; see also its spectral data in Ref. 15.
4.2.3. 14,15-Dihydrogeranylgeraniol (6a)
Similar to the synthesis of geranyl acetate (2b, see Section 4.2.2),
the esterification of farnesol (1a, 545 mg, 2.45 mmol) with acetic
anhydride (0.75 ml, 7.9 mmol) and DMAP (60 mg, 0.49 mmol) in
dichloromethane (20 ml) gave farnesyl acetate (2a, 490 mg, 1.85
mmol) in 76% yield: colorless oil; 1H NMR (CDCl3, 400 MHz) d =
5.34 (1H, t, J = 7 Hz, 2-H), 5.11–5.06 (2H, m, 6-, 10-H), 4.58 (2H,
d, J = 7 Hz, CH2O), 2.14–1.95 (8H, m, 3-, 4-, 7-, 8-CH2), 2.05 (3H,
s, 1-OCOCH3), 1.70 (3H, s, 3-CH3), 1.68 (3H, s, 11-CH3 trans to
C10ACH2) 1.60 (6H, s, 7-CH3, 11-CH3 cis to C10ACH2); see also
its spectral data in Ref. 15.
Similar to the synthesis of 8-hydroxy-farnesyl acetate (3b, see
Section 4.2.2), the above acetate 2a (490 mg, 1.85 mmol) in dichlo-
romethane (10 ml) was oxidized by an aqueous 70% tert-butyl
hydroperoxide solution (1.0 ml, 7.3 mmol), salicylic acid (60 mg,
0.43 mmol), and selenium oxide (13 mg, 0.12 mmol) for 1 day to
give 12-hydroxy-farnesyl acetate (3a, 142 mg, 0.506 mmol) in
27% isolated yield: colorless oil; 1H NMR (CDCl3, 600 MHz) d =
5.39 (1H, t, J = 7 Hz, 10-H), 5.34 (1H, t, J = 7 Hz, 2-H), 5.10 (1H, t, J
= 7 Hz, 6-H), 4.59 (2H, d, J = 7 Hz, CH2OAc), 3.99 (2H, s, 11-CH2),
2.15–2.00 (8H, m, 3-, 4-, 7-, 8-CH2), 2.05 (3H, s, 1-OCOCH3), 1.71
(3H, s, 11-CH3), 1.67 (3H, s, 3-CH3), 1.60 (3H, s, 7-CH3) [The 12-
OH was invisible.]; see also its spectral data in Ref. 15.
Similar to the synthesis of 8-diethoxyphosphoryloxy-geranyl
acetate (4b, see Section 4.2.2), the esterification of the above alco-
hol 3a (142 mg, 506
1100 mol) and DMAP (60 mg, 491
diethoxyphosphoryloxy-farnesyl acetate (4a, 134 mg, 322
l
mol) with diethyl chlorophosphate (190 mg,
mol) for 3 h gave 12-
mol)
The above alcohol 3b (60 mg, 283
dichloromethane (2 ml), to which were added diethyl chlorophos-
phate (103.2 mg, 598 mol) and DMAP (60 mg, 491 mol). The ice-
lmol) was dissolved in
l
l
l
l
l
in 64% yield: colorless oil; 1H NMR (CDCl3, 600 MHz) d = 5.48
(1H, t, J = 7 Hz, 10-H), 5.35 (1H, t, J = 7 Hz, 2-H), 5.11 (1H, t, J = 7
Hz, 6-H), 4.59 (2H, d, J = 7 Hz, CH2OAc), 4.39 (2H, s, 11-CH2O),
4.11 (4H, q, J = 7 Hz, POCH2 ꢀ 2), 2.15–2.00 (8H, m, 3-, 4-, 7-, 8-
CH2), 2.05 (3H, s, 1-OCOCH3), 1.70 (3H, s, 11-CH3), 1.69 (3H, s, 3-
CH3), 1.60 (3H, s, 7-CH3), 1.33 (6H, t, J = 7 Hz, POCCH3 ꢀ 2).
Similar to the synthesis of 10,11-dihydrogeranylgeraniol (6b),
isopentylmagnesium bromide prepared by magnesium (72 mg,
3.0 mmol), a piece of iodine, and 1-bromo-3-methylbutane (5a,
cooled mixture was stirred under nitrogen for 6 h and the reaction
was quenched with distilled water. After extraction with diethyl
ether, the organic phase was washed twice with aq. 0.1 M hydro-
gen chloride, distilled water, and brine and dried over sodium sul-
fate. All the solvents were evaporated and the residue was purified
with FCC (hexane:ethyl acetate:methanol = 50:50:1) to give 8-
diethoxyphosphoryloxy-geranyl acetate (4b, 63 mg, 181 lmol) in
64% yield: colorless oil; 1H NMR (CDCl3, 600 MHz) d = 5.48 (1H,
m, 6-H), 5.34 (1H, m, 2-H), 4.58 (2H, d, J = 7 Hz, CH2OAc), 4.39
(2H, m, 7-CH2O), 4.15–4.07 (4H, m, POCH2 ꢀ 2), 2.20–2.07 (4H,
m, 3-CH2CH2), 2.06 (3H, s, 1-OCOCH3), 1.70 (3H, s, 3-CH3), 1.69
(3H, s, 7-CH3), 1.33 (6H, t, J = 7 Hz, POCCH3 ꢀ 2).
isopentyl bromide, 313
ml) for 2 h, was reacted with the above phosphate 4a (134 mg,
322 mol) to give 14,15-DHGG-OH 6a (26 mg, 89 mol) in 28%
ll, 375 mg, 2.48 mmol) in dry THF (10+5
l
l
yield: colorless oil; 1H NMR (CD3OD, 600 MHz) d = 5.36 (1H, tq, J
= 7, 2 Hz, 2-H), 5.14 (1H, tq, J = 7, 2 Hz, 6-H), 5.10 (1H, tq, J = 7, 2
Hz, 10-H), 4.08 (2H, d, J = 7 Hz, CH2O), 2.13, 2.09 (each 2H, q, J =
8 Hz, 4-, 8-CH2), 2.04 (2H, t, J = 8 Hz, 3-CH2), 2.00 (2H, t, J = 8 Hz,
7-CH2), 1.95 (2H, t, J = 7 Hz, 11-CH2), 1.67 (3H, s, 3-CH3), 1.61
(3H, s, 7-CH3), 1.58 (3H, s, 11-CH3), 1.53 (1H, nonet, J = 7 Hz, 15-
H), 1.39 (2H, quintet, J = 7 Hz, 12-CH2), 1.14 (2H, q, J = 7 Hz, 13-
CH2), 0.88 (6H, d, J = 7 Hz, 15-CH3 ꢀ 2) [The 1-OH was invisible.];
13C NMR (CD3OD, 151 MHz) d = 139.44, 136.15, 136.13, 125.29,
125.26, 124.92, 59.43, 40.96, 40.81, 40.75, 39.72, 29.07, 27.53,
27.45, 26.84, 23.04 (15-C2), 16.26, 16.05, 15.96; HRMS (APCI)
found: m/z 291.2678, calcd for C20H35O: [MꢂH]+, 291.2682.
Dry THF (15 ml) was added to magnesium (170 mg, 7.0 mmol)
and a piece of iodine under argon. (R)-Citronellyl bromide (5b,
1.5 g, 6.8 mmol) was slowly dropped into the stirred mixture at
room temperature and THF (30 ml) was further added with stirring
for 1 h. To the THF solution of the resulting Grignard reagent was
gradually added the above phosphate (636 mg, 1.83 mmol). After
stirring for 4 h at room temperature, the reaction was quenched
with aq. 1% ammonium chloride and the mixture was extracted
with diethyl ether. The ethereal phase was washed with distilled
water and dried over sodium sulfate. All the solvents were evapo-
rated and the residue was purified with FCC (hexane:ethyl acetate
= 6:1) and RP-HPLC (acetonitrile) to give (11S)-10,11-DHGG-OH 6b
(80 mg, 273
l
mol) in 15% yield: colorless oil; 1H NMR (CD3OD, 600
4.3. Preparation of tetrahydrogeranylgeraniols
MHz) d = 5.36 (1H, tq, J = 7, 2 Hz, 2-H), 5.13 (1H, br-t, J = 7 Hz, 6-H),
5.10 (1H, br-t, J = 7 Hz, 14-H), 4.08 (2H, d, J = 7 Hz, CH2O), 2.13 (2H,
q, J = 7 Hz, 4-CH2), 2.04 (2H, t, J = 7 Hz, 3-CH2), 2.01–1.92 (4H, m,
7-, 12-CH2), 1.68 (3H, s, 15-CH3 trans to C14ACH2), 1.67 (3H, s,
4.3.1. 6,7,10,11-Tetrahydrogeranylgeraniol
Wet cells from a fully grown liquid culture of the Rhodopseu-
domonas sp. Rits strain22 were treated with a 1:1 (v/v) mixture of